Skip to main content
Caplight Logo









Celltrio

Celltrio

Private
Fremont, CaliforniaHealthcare & Life Scienceshttps://celltrio.com/

Last Round

Early Funding

Jun 17, 2025

Total Funding Raised

$15M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Celltrio is a biotechnology company that develops and manufactures robotic-based solutions and modular lab automation systems for the life sciences industry.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Industrial Robotics, Drug Discovery, Workflow Automation

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

lab automationcell culture automationbiobankingrobotic cell cultureautomated liquid handlingcryogenic storagecell line developmentbiotech roboticsgood manufacturing practiceGMPworkflow automationcell therapy manufacturinglab-in-a-boxautomated labdrug discovery tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Celltrio Comparables

Compare Celltrio with similar companies based on industry and business-model similarity.

Celltrio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Multiply Labs
87%
Cellular Origins
85%
Ori Biotech
80%

Celltrio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJun 17, 2025

Key People

Founding team and executive leadership

Jeff Baird

President & COO, Chief Operating Officer

Executive Team

Celltrio Investors

Notable investors and investment history

Celltrio investors
InvestorRounds
Asia2G CapitalEarly Funding
Premier PartnersEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 24, 2026

    Grew 19% QoQ, from 31 to 37 employees.

  • Jun 19, 2026

    Monthly visitors grew 184% MoM, reaching 3K.

Celltrio Filings

Explore SEC and related filing metadata, where available.

Celltrio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Celltrio's valuation, stock price, and market status.

Is Celltrio a public or private company?

Celltrio is a private company.

What is the current stock price of Celltrio?

Celltrio is a private company with no public stock price. No recent secondary market data is available.

How much is Celltrio worth (valuation)?

Valuation information for Celltrio is not publicly available.

Can I buy Celltrio stock?

Celltrio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Celltrio's last funding round?

Celltrio's most recent funding round was Series B on June 17, 2025.

Who are the main investors in Celltrio?

Key investors in Celltrio include Premier Partners.

Will Celltrio IPO soon?

No public IPO plans have been announced for Celltrio.

How can I track Celltrio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Celltrio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFremont, California
Employee Range37
Year Founded2018
Last FundingJun 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?